NYSE: CTLTCatalent Inc Stock Ownership - Who owns Catalent?
Insider buying vs selling
Have Catalent Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott Gunther | SVP Quality Reg. Affairs | 2024-03-15 | 387 | $56.20 | $21.75kSell |
| Christa Kreuzburg | Director | 2024-01-25 | 523 | $50.41 | $26.36kSell |
| Aristippos Gennadios | Group Pres. Pharma Consumer | 2023-12-08 | 367 | $37.18 | $13.65kSell |
| Ricky Hopson | Pres. Clinical Dev Supply Div | 2023-12-08 | 256 | $37.18 | $9.52kSell |
| Alessandro Maselli | President CEO | 2023-12-08 | 1,924 | $37.18 | $71.53kSell |
| Scott Gunther | SVP Quality Reg. Affairs | 2023-12-08 | 250 | $37.18 | $9.30kSell |
| Christa Kreuzburg | Director | 2023-10-27 | 1,245 | $39.32 | $48.95kSell |
| Patricia Hunt | Pres. Consumer Health Div | 2023-10-16 | 22 | $46.52 | $1.02kSell |
| Michelle R. Ryan | Director | 2023-08-31 | 1,000 | $49.98 | $49.98kBuy |
| John J. Greisch | Executive Chair | 2023-08-30 | 21,000 | $50.24 | $1.06MBuy |
CTLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CTLT insiders and whales buy or sell their stock.
CTLT Shareholders
What type of owners hold Catalent Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackstone Healthcare Partners LLC | 22.15% | 40,030,960 | $2.24B | Insider |
| Vanguard Group Inc | 11.17% | 20,186,499 | $1.13B | Institution |
| Capital World Investors | 10.56% | 19,079,994 | $1.07B | Institution |
| Blackrock Inc | 8.95% | 16,176,100 | $906.67M | Institution |
| Janus Henderson Group PLC | 7.33% | 13,249,339 | $742.63M | Institution |
| Nomura Holdings Inc | 6.36% | 11,487,342 | $643.87M | Institution |
| T Rowe Price Investment Management Inc | 6.20% | 11,209,374 | $628.29M | Institution |
| Peter Zippelius | 4.80% | 8,672,903 | $486.12M | Insider |
| Price T Rowe Associates Inc | 4.66% | 8,427,340 | $472.35M | Institution |
| State Street Corp | 4.13% | 7,456,058 | $417.91M | Institution |
CTLT vs Pharmaceutical Stocks
Catalent Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.